Pre-cancerous breast lesions: Implications for breast cancer prevention trials
- 1 January 1992
- journal article
- clinical trial
- Published by Elsevier in International Journal of Radiation Oncology*Biology*Physics
- Vol. 23 (5) , 1071-1078
- https://doi.org/10.1016/0360-3016(92)90915-5
Abstract
No abstract availableKeywords
This publication has 52 references indexed in Scilit:
- Recurrence after lumpectomy for comedo-type intraductal carcinoma of the breastThe American Journal of Surgery, 1990
- Effects of Tamoxifen Treatment on Plasma Lipids and Lipoprotein Lipid CompositionJournal of Clinical Endocrinology & Metabolism, 1990
- Relative risk of breast cancer varies with time since diagnosis of atypical hyperplasiaHuman Pathology, 1989
- Cyclophosphamide and tamoxifen as adjuvant therapies in the management of breast cancerBritish Journal of Cancer, 1988
- Adjuvant tamoxifen in primary breast cancer: Influence on plasma lipids and antithrombin III levelsBreast Cancer Research and Treatment, 1988
- Importance of cellular DNA content in pre-malignant breast disease and pre-invasive carcinoma of the female breastBritish Journal of Surgery, 1987
- Risk factors for breast cancer: relevance to screening.Journal of Epidemiology and Community Health, 1983
- A prospective study of the relationship between benign breast diseases and breast carcinomaPreventive Medicine, 1979
- Lobular carcinomain Situ of the breast:An approach to rational treatmentCancer, 1977
- Cystic disease of the breast: Relationship to carcinomaCancer, 1964